Chemoinformaics analysis of 24,25-dihydroxy-24-epivitamin D2/24,25-dihydroxy-24-epiergocalciferol
| Molecular Weight | 428.657 | nRot | 5 |
| Heavy Atom Molecular Weight | 384.305 | nRig | 20 |
| Exact Molecular Weight | 428.329 | nRing | 3 |
| Solubility: LogS | -4.399 | nHRing | 0 |
| Solubility: LogP | 4.258 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 78.5049 |
| nHD | 3 | BPOL | 44.1411 |
| QED | 0.48 |
| Synth | 4.905 |
| Natural Product Likeliness | 2.379 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.865 |
| Pgp-sub | 0.003 |
| HIA | 0.009 |
| CACO-2 | -4.719 |
| MDCK | 0.00000657 |
| BBB | 0.948 |
| PPB | 0.96309 |
| VDSS | 1.385 |
| FU | 0.0310564 |
| CYP1A2-inh | 0.06 |
| CYP1A2-sub | 0.479 |
| CYP2c19-inh | 0.159 |
| CYP2c19-sub | 0.846 |
| CYP2c9-inh | 0.495 |
| CYP2c9-sub | 0.094 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.621 |
| CYP3a4-sub | 0.825 |
| CL | 2.092 |
| T12 | 0.12 |
| hERG | 0.032 |
| Ames | 0.024 |
| ROA | 0.172 |
| SkinSen | 0.286 |
| Carcinogencity | 0.181 |
| EI | 0.008 |
| Respiratory | 0.609 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.659739 |